Castle Biosciences Inc
NASDAQ:CSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
Tetra Tech Inc
NASDAQ:TTEK
|
US |
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
Wall St Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CSTL is 48.07 USD with a low forecast of 40.4 USD and a high forecast of 54.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CSTL's stock price target?
Price Target
48.07
USD
According to Wall Street analysts, the average 1-year price target for
CSTL is 48.07 USD with a low forecast of 40.4 USD and a high forecast of 54.6 USD.
What is the Revenue forecast for Castle Biosciences Inc?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Revenue has been 47%. The projected CAGR for the next 8 years is 7%.